GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
GLENMARK PHARMACEUTICALS Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,388 Cr | ₹3,434 Cr | ₹3,244 Cr | ₹3,063 Cr | ₹2,507 Cr | ₹3,207 Cr | ₹3,036 Cr | ₹3,001 Cr |
Expenses | ₹2,787 Cr | ₹2,832 Cr | ₹2,656 Cr | ₹2,559 Cr | ₹2,715 Cr | ₹2,745 Cr | ₹2,599 Cr | ₹2,603 Cr |
Operating Income | ₹600 Cr | ₹602 Cr | ₹588 Cr | ₹504 Cr | ₹-209 Cr | ₹462 Cr | ₹437 Cr | ₹398 Cr |
Other Income | ₹31 Cr | ₹39 Cr | ₹31 Cr | ₹773 Cr | ₹45 Cr | ₹2 Cr | ₹20 Cr | ₹-42 Cr |
Interest | ₹52 Cr | ₹48 Cr | ₹40 Cr | ₹149 Cr | ₹134 Cr | ₹121 Cr | ₹112 Cr | ₹109 Cr |
Depreciation | ₹123 Cr | ₹120 Cr | ₹118 Cr | ₹151 Cr | ₹147 Cr | ₹141 Cr | ₹142 Cr | ₹135 Cr |
Profit Before Tax | ₹456 Cr | ₹473 Cr | ₹462 Cr | ₹531 Cr | ₹-521 Cr | ₹-124 Cr | ₹151 Cr | ₹-688 Cr |
Profit After Tax | ₹348 Cr | ₹354 Cr | ₹340 Cr | ₹-1,239 Cr | ₹-450 Cr | ₹-180 Cr | ₹38 Cr | ₹-549 Cr |
EPS | ₹12.33 | ₹12.55 | ₹12.06 | ₹-43.17 | ₹-12.45 | ₹-2.90 | ₹5.31 | ₹-15.18 |
Industry Peers & Returns | 1W | 1M | 1Y |
GLENMARK PHARMACEUTICALS | 1.9% | 4.8% | 41.7% |
SUN PHARMACEUTICAL INDUSTRIES | -3.3% | 3.4% | 13.9% |
DIVIS LABORATORIES | 4.1% | 15.2% | 60.2% |
CIPLA | 0.6% | 5.6% | 11.8% |
TORRENT PHARMACEUTICALS | 1.9% | 3.7% | 28.2% |
DR REDDYS LABORATORIES | 6.2% | 11.4% | 2.6% |
MANKIND PHARMA | 4.8% | 10.2% | 17.5% |
ZYDUS LIFESCIENCES | 3.7% | 7% | -6.8% |
LUPIN | 2.9% | 7.8% | 30.2% |
GLENMARK PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.35 % |
Y-o-Y | 35.14 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹3,388 Cr | -1.35 | |
Sep2024 | ₹3,434 Cr | 5.84 | |
Jun2024 | ₹3,244 Cr | 5.92 | |
Mar2024 | ₹3,063 Cr | 22.19 | |
Dec2023 | ₹2,507 Cr | -21.85 | |
Sep2023 | ₹3,207 Cr | 5.64 | |
Jun2023 | ₹3,036 Cr | 1.18 | |
Mar2023 | ₹3,001 Cr | - |
GLENMARK PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -0.28 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹600 Cr | -0.28 | |
Sep2024 | ₹602 Cr | 2.33 | |
Jun2024 | ₹588 Cr | 16.63 | |
Mar2024 | ₹504 Cr | Positive | |
Dec2023 | ₹-209 Cr | Negative | |
Sep2023 | ₹462 Cr | 5.70 | |
Jun2023 | ₹437 Cr | 9.91 | |
Mar2023 | ₹398 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 1.08 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 17.72% | 1.08 | |
Sep2024 | 17.53% | -3.31 | |
Jun2024 | 18.13% | 10.08 | |
Mar2024 | 16.47% | Positive | |
Dec2023 | -8.32% | Negative | |
Sep2023 | 14.41% | 0.00 | |
Jun2023 | 14.41% | 8.67 | |
Mar2023 | 13.26% | - |
GLENMARK PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -1.82 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹348 Cr | -1.82 | |
Sep2024 | ₹354 Cr | 4.19 | |
Jun2024 | ₹340 Cr | Positive | |
Mar2024 | ₹-1,239 Cr | Negative | |
Dec2023 | ₹-450 Cr | Negative | |
Sep2023 | ₹-180 Cr | Negative | |
Jun2023 | ₹38 Cr | Positive | |
Mar2023 | ₹-549 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -0.48 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 10.27 % | -0.48 | |
Sep2024 | 10.32 % | -1.62 | |
Jun2024 | 10.49 % | Positive | |
Mar2024 | -40.44 % | Negative | |
Dec2023 | -17.94 % | Negative | |
Sep2023 | -5.62 % | Negative | |
Jun2023 | 1.24 % | Positive | |
Mar2023 | -18.31 % | - |
GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -1.75 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹12.33 | -1.75 | |
Sep2024 | ₹12.55 | 4.06 | |
Jun2024 | ₹12.06 | Positive | |
Mar2024 | ₹-43.17 | Negative | |
Dec2023 | ₹-12.45 | Negative | |
Sep2023 | ₹-2.9 | Negative | |
Jun2023 | ₹5.31 | Positive | |
Mar2023 | ₹-15.18 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD